High compliance in an ambulatory tuberculosis treatment programme in a rural community of Uganda. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


High compliance in an ambulatory tuberculosis treatment programme in a rural community of Uganda.

Int J Tuberc Lung Dis. 1999 Jan;3(1):79-81. Unique Identifier : AIDSLINE MED/99191962
Nuwaha F; Department of Community Health, Mbarara University, Uganda.

Abstract: The increasing numbers of clinical tuberculosis in Uganda, mainly due to the human immunodeficiency virus (HIV) epidemic, means that it is no longer possible to hospitalise all TB patients, and the feasibility of ambulatory treatment needs to be assessed. A successful ambulatory TB treatment programme has been implemented in Rakai district. An annual cohort analysis for the period 1992-1996 showed that high completion rates were achieved. Of a total of 1659 TB patients, 92% of those surviving completed the prescribed treatment. Reasons for this high completion rate included: treating patients at one health unit, treating patients near their homes, training and supervision of health workers, and progressive use of short-course chemotherapy.
Keywords: JOURNAL ARTICLE *Ambulatory Care Antitubercular Agents/*THERAPEUTIC USE Human *Patient Compliance Rural Population Tuberculosis, Pulmonary/*DRUG THERAPY UgandaKWDjournalarticleKWDambulatorycareantitubercularagents/KWDtherapeuticusehumanKWDpatientcomplianceruralpopulationtuberculosis,pulmonary/KWDdrugtherapyuganda
990730
A9971163

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .